BlackRock Capital Allocation Trust (BCAT) Stock Forecast

NYSE: BCATAnalyst ratings, price target and estimates.

BCAT analyst forecast

as of October 18, 2026
Analyst consensus
Hold
3.00 / 5 from 1 analysts
Price target
—
average of analyst targets
Upside to target
—
from the latest close
Next earnings
—
52-week range
$13.02 – $16.19

BCAT analyst ratings

1 analysts
Strong buy
00%
Buy
00%
Hold
1100%
Sell
00%
Strong sell
00%

Number of analysts at each rating.

BCAT earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 4 quarters; BCAT beat in 2 of 4.

What analysts expect from BCAT

1 analysts cover BlackRock Capital Allocation; their consensus rating is hold (3.00 on a 1–5 scale, where 5 is a strong buy). BlackRock Capital Allocation beat the EPS estimate in 2 of the last 4 quarters.

Related: BCAT income statement, BCAT key metrics, BCAT chart. See the BCAT stock overview for the latest quote and news.

BCAT forecast FAQ

Is BlackRock Capital Allocation a buy, hold or sell?

Of 1 analysts covering BlackRock Capital Allocation, 0 rate it a strong buy, 0 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of hold. Ratings are opinions, not a recommendation from Quotelinks.

Does BlackRock Capital Allocation usually beat earnings estimates?

BlackRock Capital Allocation reported EPS at or above the analyst estimate in 2 of the last 4 quarters.

Asset Management: forecast